Cargando…

Deregulation of Secreted Frizzled-Related Protein 5 in Nonalcoholic Fatty Liver Disease Associated with Obesity

Secreted frizzled-related protein 5 (SFRP5), an antagonist of the noncanonical WNT pathway, has a controversial role in liver disease. The aim of this study was to analyze the role of SFRP5 and the noncanonical WNT pathway in nonalcoholic fatty liver disease (NAFLD). Plasma SFRP5 levels were determi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertran, Laia, Portillo-Carrasquer, Marta, Aguilar, Carmen, Porras, José Antonio, Riesco, David, Martínez, Salomé, Vives, Margarita, Sabench, Fàtima, Gonzalez, Eva, Del Castillo, Daniel, Richart, Cristóbal, Auguet, Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268103/
https://www.ncbi.nlm.nih.gov/pubmed/34198988
http://dx.doi.org/10.3390/ijms22136895
_version_ 1783720283479212032
author Bertran, Laia
Portillo-Carrasquer, Marta
Aguilar, Carmen
Porras, José Antonio
Riesco, David
Martínez, Salomé
Vives, Margarita
Sabench, Fàtima
Gonzalez, Eva
Del Castillo, Daniel
Richart, Cristóbal
Auguet, Teresa
author_facet Bertran, Laia
Portillo-Carrasquer, Marta
Aguilar, Carmen
Porras, José Antonio
Riesco, David
Martínez, Salomé
Vives, Margarita
Sabench, Fàtima
Gonzalez, Eva
Del Castillo, Daniel
Richart, Cristóbal
Auguet, Teresa
author_sort Bertran, Laia
collection PubMed
description Secreted frizzled-related protein 5 (SFRP5), an antagonist of the noncanonical WNT pathway, has a controversial role in liver disease. The aim of this study was to analyze the role of SFRP5 and the noncanonical WNT pathway in nonalcoholic fatty liver disease (NAFLD). Plasma SFRP5 levels were determined by ELISA in women with normal weight (NW; n = 20) and morbid obesity (MO; n = 69). Women with MO were subclassified according to hepatic histology into normal liver (NL; n = 28), NAFLD (n = 41) (simple steatosis (SS; n = 24), and nonalcoholic steatohepatitis (NASH; n = 17)). We used RT-qPCR to evaluate the hepatic mRNA expression of SFRP5, WNT5A, and JNK in women with MO. SFRP5 levels were lower in NW than in MO patients who underwent a very low-calorie diet before surgery. Hepatic SFRP5 mRNA expression was higher in SS than in NL or NASH; additionally, patients with hepatic inflammation or ballooning presented lower SFRP5 abundance. WNT5A and JNK expression was enhanced in NAFLD compared with NL. In conclusion, circulating SFRP5 levels depend on the diet, and hepatic SFRP5 seems to have a protective role in the first steps of NAFLD; however, SFRP5 could be deregulated in an advanced stage while WNT5A and JNK are activated, promoting liver damage.
format Online
Article
Text
id pubmed-8268103
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82681032021-07-10 Deregulation of Secreted Frizzled-Related Protein 5 in Nonalcoholic Fatty Liver Disease Associated with Obesity Bertran, Laia Portillo-Carrasquer, Marta Aguilar, Carmen Porras, José Antonio Riesco, David Martínez, Salomé Vives, Margarita Sabench, Fàtima Gonzalez, Eva Del Castillo, Daniel Richart, Cristóbal Auguet, Teresa Int J Mol Sci Article Secreted frizzled-related protein 5 (SFRP5), an antagonist of the noncanonical WNT pathway, has a controversial role in liver disease. The aim of this study was to analyze the role of SFRP5 and the noncanonical WNT pathway in nonalcoholic fatty liver disease (NAFLD). Plasma SFRP5 levels were determined by ELISA in women with normal weight (NW; n = 20) and morbid obesity (MO; n = 69). Women with MO were subclassified according to hepatic histology into normal liver (NL; n = 28), NAFLD (n = 41) (simple steatosis (SS; n = 24), and nonalcoholic steatohepatitis (NASH; n = 17)). We used RT-qPCR to evaluate the hepatic mRNA expression of SFRP5, WNT5A, and JNK in women with MO. SFRP5 levels were lower in NW than in MO patients who underwent a very low-calorie diet before surgery. Hepatic SFRP5 mRNA expression was higher in SS than in NL or NASH; additionally, patients with hepatic inflammation or ballooning presented lower SFRP5 abundance. WNT5A and JNK expression was enhanced in NAFLD compared with NL. In conclusion, circulating SFRP5 levels depend on the diet, and hepatic SFRP5 seems to have a protective role in the first steps of NAFLD; however, SFRP5 could be deregulated in an advanced stage while WNT5A and JNK are activated, promoting liver damage. MDPI 2021-06-27 /pmc/articles/PMC8268103/ /pubmed/34198988 http://dx.doi.org/10.3390/ijms22136895 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bertran, Laia
Portillo-Carrasquer, Marta
Aguilar, Carmen
Porras, José Antonio
Riesco, David
Martínez, Salomé
Vives, Margarita
Sabench, Fàtima
Gonzalez, Eva
Del Castillo, Daniel
Richart, Cristóbal
Auguet, Teresa
Deregulation of Secreted Frizzled-Related Protein 5 in Nonalcoholic Fatty Liver Disease Associated with Obesity
title Deregulation of Secreted Frizzled-Related Protein 5 in Nonalcoholic Fatty Liver Disease Associated with Obesity
title_full Deregulation of Secreted Frizzled-Related Protein 5 in Nonalcoholic Fatty Liver Disease Associated with Obesity
title_fullStr Deregulation of Secreted Frizzled-Related Protein 5 in Nonalcoholic Fatty Liver Disease Associated with Obesity
title_full_unstemmed Deregulation of Secreted Frizzled-Related Protein 5 in Nonalcoholic Fatty Liver Disease Associated with Obesity
title_short Deregulation of Secreted Frizzled-Related Protein 5 in Nonalcoholic Fatty Liver Disease Associated with Obesity
title_sort deregulation of secreted frizzled-related protein 5 in nonalcoholic fatty liver disease associated with obesity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268103/
https://www.ncbi.nlm.nih.gov/pubmed/34198988
http://dx.doi.org/10.3390/ijms22136895
work_keys_str_mv AT bertranlaia deregulationofsecretedfrizzledrelatedprotein5innonalcoholicfattyliverdiseaseassociatedwithobesity
AT portillocarrasquermarta deregulationofsecretedfrizzledrelatedprotein5innonalcoholicfattyliverdiseaseassociatedwithobesity
AT aguilarcarmen deregulationofsecretedfrizzledrelatedprotein5innonalcoholicfattyliverdiseaseassociatedwithobesity
AT porrasjoseantonio deregulationofsecretedfrizzledrelatedprotein5innonalcoholicfattyliverdiseaseassociatedwithobesity
AT riescodavid deregulationofsecretedfrizzledrelatedprotein5innonalcoholicfattyliverdiseaseassociatedwithobesity
AT martinezsalome deregulationofsecretedfrizzledrelatedprotein5innonalcoholicfattyliverdiseaseassociatedwithobesity
AT vivesmargarita deregulationofsecretedfrizzledrelatedprotein5innonalcoholicfattyliverdiseaseassociatedwithobesity
AT sabenchfatima deregulationofsecretedfrizzledrelatedprotein5innonalcoholicfattyliverdiseaseassociatedwithobesity
AT gonzalezeva deregulationofsecretedfrizzledrelatedprotein5innonalcoholicfattyliverdiseaseassociatedwithobesity
AT delcastillodaniel deregulationofsecretedfrizzledrelatedprotein5innonalcoholicfattyliverdiseaseassociatedwithobesity
AT richartcristobal deregulationofsecretedfrizzledrelatedprotein5innonalcoholicfattyliverdiseaseassociatedwithobesity
AT auguetteresa deregulationofsecretedfrizzledrelatedprotein5innonalcoholicfattyliverdiseaseassociatedwithobesity